[go: up one dir, main page]

DK670587D0 - Fremgangsmaade til screening af stabiliseringsmidler til rta- og rta-immunkonjugatpraeparater samt stabile farmaceutiske sammensaetninger omfattende rta-immunkonjugater - Google Patents

Fremgangsmaade til screening af stabiliseringsmidler til rta- og rta-immunkonjugatpraeparater samt stabile farmaceutiske sammensaetninger omfattende rta-immunkonjugater

Info

Publication number
DK670587D0
DK670587D0 DK670587A DK670587A DK670587D0 DK 670587 D0 DK670587 D0 DK 670587D0 DK 670587 A DK670587 A DK 670587A DK 670587 A DK670587 A DK 670587A DK 670587 D0 DK670587 D0 DK 670587D0
Authority
DK
Denmark
Prior art keywords
rta
immunconjugate
immunconjugates
preparations
procedure
Prior art date
Application number
DK670587A
Other languages
English (en)
Other versions
DK670587A (da
Inventor
Robert Ferris
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of DK670587D0 publication Critical patent/DK670587D0/da
Publication of DK670587A publication Critical patent/DK670587A/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/02Food
    • G01N33/14Beverages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817Toxins
    • A61K47/6819Plant toxins
    • A61K47/6825Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
    • A61K47/6827Ricin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/861Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgG3, IgG4, IgA, or IgY

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Botany (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK670587A 1986-12-19 1987-12-18 Fremgangsmaade til screening af stabiliseringsmidler til rta- og rta-immunkonjugatpraeparater samt stabile farmaceutiske sammensaetninger omfattende rta-immunkonjugater DK670587A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/944,347 US4808705A (en) 1986-12-19 1986-12-19 Stable formulations of ricin toxin a chain and of RTA-immunoconjugates and stabilizer screening methods therefor

Publications (2)

Publication Number Publication Date
DK670587D0 true DK670587D0 (da) 1987-12-18
DK670587A DK670587A (da) 1988-06-20

Family

ID=25481236

Family Applications (1)

Application Number Title Priority Date Filing Date
DK670587A DK670587A (da) 1986-12-19 1987-12-18 Fremgangsmaade til screening af stabiliseringsmidler til rta- og rta-immunkonjugatpraeparater samt stabile farmaceutiske sammensaetninger omfattende rta-immunkonjugater

Country Status (11)

Country Link
US (1) US4808705A (da)
EP (1) EP0271918A3 (da)
JP (1) JPS63258426A (da)
AU (1) AU593489B2 (da)
CA (1) CA1305417C (da)
DK (1) DK670587A (da)
FI (1) FI875608A7 (da)
HU (1) HUT45401A (da)
IE (1) IE873452L (da)
IL (1) IL84876A0 (da)
NO (1) NO875232L (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5393512A (en) * 1985-01-14 1995-02-28 Vanderheyden; Jean-Luc Stable therapeutic radionuclide compositions and methods for preparation thereof
US5116944A (en) * 1989-12-29 1992-05-26 Neorx Corporation Conjugates having improved characteristics for in vivo administration
US5270057A (en) * 1990-03-20 1993-12-14 Akzo N.V. Stabilized gonadotropin containing preparations
KR100361933B1 (ko) * 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
EP1056474B1 (en) * 1997-11-07 2002-06-12 ConjuChem, Inc. Affinity markers for human serum albumin
US6458953B1 (en) * 1998-12-09 2002-10-01 La Jolla Pharmaceutical Company Valency platform molecules comprising carbamate linkages
US20070020662A1 (en) * 2000-01-07 2007-01-25 Transform Pharmaceuticals, Inc. Computerized control of high-throughput experimental processing and digital analysis of comparative samples for a compound of interest
US20070021929A1 (en) * 2000-01-07 2007-01-25 Transform Pharmaceuticals, Inc. Computing methods for control of high-throughput experimental processing, digital analysis, and re-arraying comparative samples in computer-designed arrays
WO2001093914A2 (en) * 2000-06-08 2001-12-13 La Jolla Pharmaceutical Company Multivalent platform molecules comprising high molecular weight polyethylene oxide
ES2330508T3 (es) * 2000-11-07 2009-12-11 Novartis Vaccines And Diagnostics, Inc. Composiciones de interferon estabiladas.
CA2454587C (en) 2001-07-25 2012-11-13 Protein Design Labs, Inc. Stable lyophilized pharmaceutical formulation of igg antibodies
US20100210027A9 (en) * 2002-11-04 2010-08-19 Hongming Chen Method for determining effect of preformulation forms on their dissolution rates
CN100418585C (zh) * 2003-07-24 2008-09-17 伯拉考成像股份公司 稳定的放射性药物组合物及制备方法
FR2877565A1 (fr) * 2004-11-09 2006-05-12 Oreal Utilisation d'un sulfate de dextran de haut poids moleculaire comme agent apaisant
JP2009502972A (ja) * 2005-07-29 2009-01-29 アムジエン・インコーポレーテツド タンパク質凝集を抑制する製剤
EP1980853A1 (en) * 2007-04-11 2008-10-15 Alfresa Pharma Corporation Method of preventing precipitation of a reactive substance-bound microparticle, and reagent containing the micro particle
US20080261328A1 (en) * 2007-04-19 2008-10-23 Alfresa Pharma Corporation Method of preventing precipitation of a reactive substance-bound microparticle, and reagent containing the micro particle
PT2310412T (pt) 2008-06-20 2018-05-28 Novartis Ag Imunoglobulinas com agregação reduzida
CA2794631A1 (en) 2010-03-31 2011-10-06 Universite De Geneve Stabilized antibody preparations and uses thereof
JP2013523717A (ja) 2010-03-31 2013-06-17 ユニベルシテ ドゥ ジュネーブ 安定化された抗体調製物およびその使用
GB201717966D0 (en) * 2017-10-31 2017-12-13 Xenikos Bv Immunotoxins, formulations thereof and their use in medicine
CN111781345A (zh) * 2020-06-30 2020-10-16 上海透景生命科技股份有限公司 化学发光标记物标记抗原稳定剂及其应用
CN119498456A (zh) * 2024-12-10 2025-02-25 山东海创工贸有限公司 一种利用奶制品和肉产品作为原料的宠物湿粮及其制作方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4623717A (en) * 1980-03-05 1986-11-18 Miles Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4439181A (en) * 1981-01-26 1984-03-27 Regents Of The University Of Minnesota Polyol-hormone mixture for use in chronic parenteral hormone administration
JPS59116229A (ja) * 1982-12-24 1984-07-05 Teijin Ltd 細胞毒性複合体を活性成分とする癌治療用剤およびその製造法
US4664911A (en) * 1983-06-21 1987-05-12 Board Of Regents, University Of Texas System Immunotoxin conjugates employing toxin B chain moieties
ATE87318T1 (de) * 1985-11-29 1993-04-15 Consolidated Pharmaceuticals L Ricin-antikoerper-konjugate.

Also Published As

Publication number Publication date
US4808705A (en) 1989-02-28
CA1305417C (en) 1992-07-21
FI875608A7 (fi) 1988-06-20
NO875232L (no) 1988-06-20
FI875608A0 (fi) 1987-12-18
AU8280187A (en) 1988-06-23
IE873452L (en) 1988-06-19
EP0271918A3 (en) 1989-12-13
DK670587A (da) 1988-06-20
EP0271918A2 (en) 1988-06-22
IL84876A0 (en) 1988-06-30
NO875232D0 (no) 1987-12-15
AU593489B2 (en) 1990-02-08
HUT45401A (en) 1988-07-28
JPS63258426A (ja) 1988-10-25

Similar Documents

Publication Publication Date Title
DK670587D0 (da) Fremgangsmaade til screening af stabiliseringsmidler til rta- og rta-immunkonjugatpraeparater samt stabile farmaceutiske sammensaetninger omfattende rta-immunkonjugater
DK149988A (da) Stabile farmaceutiske praeparater
DK160985C (da) Asymmetriske diestere af 1,4-dihydro-2,6-dimethyl-pyridin-3,5-dicarboxylsyre, fremgangsmaader til fremstilling heraf samt farmaceutiske praeparater indeholdende disse
MX9203099A (es) N-heterociclico-n-(4-piperidia)amidas y composiciones farmaceuticas y metodos que emplean dichos compuestos.
IT8947546A0 (it) Composti nucleosidi dideossidideidrocarbociclici e formulazione farmaceutica che li contiene
DK147386D0 (da) Derivater af methylen-bisphosphonsyre, fremgangsmaade til fremstillingaf samme samt farmaceutisk sammensaetning
DK56891D0 (da) Anvendelse af pesticidpraeparater
DK47787A (da) Dihydropyridinderivatholdige retardpraeparater
DK325487A (da) Farmaceutiske sammensaetninger til parenteral applikation samt deres fremstilling
DK162892C (da) 1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK652787A (da) Farmaceutiske praeparater
DK342187A (da) 4-pyridin-derivater, fremgangsmaade til fremstilling af saadanne derivater samt farmaceutiske praeparater indeholdende disse
KR900012897A (ko) 구아니딘 유도체 및 이를 함유하는 약제학적 조성물
MX172943B (es) Formulacion farmaceutica
DK202286D0 (da) Dihydropyridin-forbindelser og deres anvendelse til fremstilling af antiisohaemiske eller antihypertensive midler samt farmaceutiske praeparater indeholdende forbindelserne
DK447887A (da) Frysetoerrede farmaceutiske praeparater
DK141487D0 (da) Pesticider indeholdende 1-aryl-4-trifluormethyl-5-aminopyrazoler samt 1-aryl-4-trifluormethyl-5-aminopyrazoler og fremgangsmaader til deres fremstilling
DK93385D0 (da) 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazoliner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser
IT1216814B (it) Composizioni farmaceutiche
DK369088A (da) Fremgangsmaade til fremstilling af nukleinsyrederivater og fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende disse
DK701588A (da) N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater
KR900700471A (ko) 신규의 2,3-티오모르폴린디온-2-옥심유도체, 이들을 함유하는 약제학적 조성물 및 제법
DK289887D0 (da) Anvendelse af avaron- og avarolderivater
DK289987D0 (da) Anvendelse af avaron- og avarolderivater
DK328087A (da) N-imidazolylmethyl-diphenylazomethiner samt fremgangsmaade til fremstilling af saadanne forbindelser og anvendelse af disse i farmaceutiske praeparater

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment